Developing New Treatments for Mania Using Brain-Based Risk Markers

Tuesday, November 9, 2021, 2:00 pm EST
Meet the Scientist - November 2021

Bipolar Disorder is a severe and often disabling disorder that is difficult to diagnose, and is also difficult to treat effectively, as many of the treatments that are currently available cause intolerable side effects. The latter is especially true of several of the medications that are used to treat mania, a key symptom of the disorder. My talk will demonstrate how advances in brain imaging research in sufferers of Bipolar Disorder and in adolescents and young adults at future risk of the disorder can identify brain-based markers to aid earlier diagnosis, and provide brain-based targets to help develop new brain stimulation treatments for the disorder that have fewer side effects than traditionally-used medications.

Watch webinar recording:

Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

Sign up for other upcoming webinars.

View past webinar recordings.

Presented by 
Mary L. Phillips M.D., M.D. (Cantab)
Mary L. Phillips M.D., M.D. (Cantab)
University of Pittsburgh / Western Psychiatric Institute and Clinic

Pittsburgh Foundation-Emmerling Endowed Chair in Psychotic Disorders

Professor in Psychiatry and Clinical Translational Science

Director of the Mood and Brain Laboratory, The Clinical and Translational Affective Neuroscience Program Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pa

Scientific Council Member (Joined 2016)

2017 Colvin Prize for Outstanding Achievement in Mood Disorders Research

2005 Independent Investigator Grant

Mary L. Phillips is the Pittsburgh Foundation- Emmerling Endowed Chair in Psychotic Disorders, and Professor in Psychiatry and Clinical and Translational Science in the University of Pittsburgh. She heads the Clinical and Translational Affective Neuroscience Program in the Department of Psychiatry at the University of Pittsburgh. Dr. Phillips trained in Medicine at Cambridge University, UK, and in Psychiatry at the Maudsley Hospital and the Institute of Psychiatry, King’s College, University of London, UK.

Moderated by 
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation

President and CEO

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.